beta-2 Microglobulin Antikörper (HRP)
Kurzübersicht für beta-2 Microglobulin Antikörper (HRP) (ABIN112400)
Target
Alle beta-2 Microglobulin (B2M) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- The antibody reacts with beta-2-Microglobulin (B2M) associated with cell-surface MHC Class I molecules and other membrane antigens as well as with soluble beta-2-Microglobulin.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
-
Immunogen
- Purified Human beta-2-Microglobulin.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
-
The antibody is designed for quantitative determination of soluble beta2-Microglobulin/MHC Class I complexes. This antibody can also be used for detection offree beta 2-Microglobulin by Western blotting. ELISA. Western blot (Both Reducing and non-Reducing conditions): Recommended Dilution: 2-4 μg/mL. Positive Control: U937 human histiocytic lymphoma cell line, RAJI human Burkitt lymphomacell line. Negative Control: EL4 mouse lymphoblastic lymphoma cell line. Sample Preparation: Resuspend approx.50 mil. cells in 1 mLcold Lysis buffer (1 % laurylmaltoside in 20 mM Tris/Cl, 100 mM NaCl pH 8.2, 50 mM NaF including Proteaseinhibitor Cocktail). Incubate 60 min on ice. Centrifuge to remove cell debris. Mix lysatewith non-reducing/reducing Laemmli SDS-PAGE sample buffer.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS, 0.01 % (w/v) Thimerosal, 1 % (w/v) high-grade protease free BSA
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- This product is photosensitive and should be protected from light
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
-
-
-
: "HLA-G5 in the blood of leukemia patients and healthy individuals." in: Leukemia research, Vol. 37, Issue 2, pp. 139-45, (2013) (PubMed).
: "Urine proteomic profiling of pediatric nephrotic syndrome." in: Pediatric nephrology (Berlin, Germany), Vol. 21, Issue 9, pp. 1257-65, (2006) (PubMed).
: "Modulation of HLA-G expression in human neural cells after neurotropic viral infections." in: Journal of virology, Vol. 79, Issue 24, pp. 15226-37, (2005) (PubMed).
: "Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast." in: Anticancer research, Vol. 19, Issue 1A, pp. 175-9, (1999) (PubMed).
-
-
- beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))
-
Andere Bezeichnung
- beta-2-Microglobulin
-
Hintergrund
- B2M non-covalently associates with the 44 kDa alpha chain to forms the HLA Class I antigen complex. Human beta2-microglobulin associated with HLA Class I antigens is expressed on many types of cells including lymphocytes, thymocytes, monocytes, granulocytes, platelets, endothelial cells, and epithelial cells. It is absent on erythrocytes.Synonyms: B2M, Beta 2 microglobulin, Beta-2 microglobulin
-
Gen-ID
- 567
-
NCBI Accession
- NP_004039
-
UniProt
- P61769
-
Pathways
- T-Zell Rezeptor Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-